National Health Investors (NYSE:NHI) Releases FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.430-4.440 for the period, compared to the consensus earnings per share estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Trading Up 0.0 %

Shares of National Health Investors stock traded up $0.03 during trading hours on Wednesday, reaching $76.76. 870,031 shares of the company’s stock were exchanged, compared to its average volume of 246,682. National Health Investors has a 52-week low of $49.25 and a 52-week high of $86.13. The company has a fifty day moving average of $80.45 and a 200-day moving average of $73.14. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). The business had revenue of $84.97 million during the quarter, compared to analyst estimates of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.06 earnings per share. Sell-side analysts forecast that National Health Investors will post 4.48 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.69%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s payout ratio is currently 122.45%.

Analyst Upgrades and Downgrades

NHI has been the subject of a number of recent analyst reports. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Truist Financial lifted their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America initiated coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.